Update on funding
15 Februar 2008 - 5:30PM
UK Regulatory
RNS Number:1455O
EiRx Therapeutics PLC
15 February 2008
EIRX THERAPEUTICS PLC
( "EiRx" or "the Company" )
Funding package
The Directors of Eirx Therapeutics plc are pleased to announce that EiRx has
agreed in principle a funding package designed to provide working capital to
fund the Company until at least 31 December 2008 comprising a placing of shares,
convertible loan stock and an enlarged bank facility along with some short term
funding.
The details of the funding package are being finalised and will be announced no
later than Thursday 21 February 2008.
For further information, please contact:
EiRx Therapeutics plc +353 (0)21 432 0847
Colin Telfer PhD, Chief Executive Officer
Grant Thornton Corporate Finance +44 (0)20 7383 5100
Philip Secrett / Colin Aaronson
About EiRx
EiRx Therapeutics (AIM: ERX) is a research-driven healthcare company developing
cutting-edge targeted therapies for the treatment of cancer. EiRx is
headquartered in Cork, Ireland, conducts drug discovery from its laboratories in
Cork and in Aberdeen, Scotland. The Company has an initial focus on tumours
arising due to anomalies in apoptosis and cellular growth regulatory pathways,
with particular relation to breast and colorectal tumours, currently two of the
four leading causes of death from cancer world-wide.
EiRx is built on leading scientific expertise in the areas of apoptosis biology,
cancer pathway biology, biomarker technologies and the metabolic basis of drug
resistance in tumours. It has established technical capabilities in target
identification, validation and cell-based screening, and is combining unique
resources such as the ACCRI-BANK clinical tissue bank, the ALIBITM functional
genomics platform and the Engineered Pathway Dependence ("EnPADTM") isogenic
cellular screening technology to create a product development engine
specialising in discovery and development of small-molecule targeted cancer
therapies and the discovery and validation of cancer biomarkers.
For further information please see our website at http://www.eirx.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCZGGMZVKRGRZM
Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024
Echtzeit-Nachrichten über Eirx Therap. (Londoner Börse): 0 Nachrichtenartikel
Weitere Eirx Therapeutic Plc News-Artikel